APA (7th ed.) Citation

Lin, C., Verma, V., Lazenby, A., Ly, Q. P., Berim, L. D., Schwarz, J. K., . . . Grem, J. L. (2019). Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma. American journal of clinical oncology, 42(10), 755. https://doi.org/10.1097/COC.0000000000000599

Chicago Style (17th ed.) Citation

Lin, Chi, et al. "Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma." American Journal of Clinical Oncology 42, no. 10 (2019): 755. https://doi.org/10.1097/COC.0000000000000599.

MLA (9th ed.) Citation

Lin, Chi, et al. "Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma." American Journal of Clinical Oncology, vol. 42, no. 10, 2019, p. 755, https://doi.org/10.1097/COC.0000000000000599.